Author: Michele Anzidei
Body Region: Chest
1. Patient presentation
- A 72-year-old man with unresectable stage IIIb lung adenocarcinoma was scheduled for treatment with carboplatin, paclitaxel and bevacizumab.
- CT perfusion imaging of the lung was performed at baseline and after 60 days, to assess the response to treatment.